UBS Group Increases Crocs (NASDAQ:CROX) Price Target to $124.00

Crocs (NASDAQ:CROXGet Free Report) had its price objective hoisted by stock analysts at UBS Group from $117.00 to $124.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on the textile maker’s stock. UBS Group’s price target suggests a potential downside of 1.41% from the company’s current price.

CROX has been the topic of several other reports. OTR Global upgraded shares of Crocs from a “mixed” rating to a “positive” rating in a research note on Thursday, April 11th. B. Riley raised their price objective on shares of Crocs from $95.00 to $122.00 and gave the company a “neutral” rating in a research report on Wednesday, April 10th. Barclays began coverage on shares of Crocs in a research report on Monday, April 1st. They set an “overweight” rating and a $167.00 price objective on the stock. Stifel Nicolaus raised their price objective on shares of Crocs from $132.00 to $140.00 and gave the company a “buy” rating in a research report on Friday, February 16th. Finally, KeyCorp raised their price objective on shares of Crocs from $130.00 to $149.00 and gave the company an “overweight” rating in a research report on Thursday, March 21st. Four investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $145.17.

Check Out Our Latest Report on CROX

Crocs Stock Performance

Shares of CROX stock opened at $125.77 on Tuesday. The stock has a market capitalization of $7.61 billion, a P/E ratio of 9.82, a PEG ratio of 1.58 and a beta of 2.01. The company has a current ratio of 1.30, a quick ratio of 0.75 and a debt-to-equity ratio of 1.13. The firm’s 50 day moving average is $128.14 and its 200 day moving average is $107.07. Crocs has a 12 month low of $74.00 and a 12 month high of $150.56.

Crocs (NASDAQ:CROXGet Free Report) last announced its quarterly earnings results on Thursday, February 15th. The textile maker reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $2.38 by $0.20. Crocs had a net margin of 20.00% and a return on equity of 61.97%. The company had revenue of $960.10 million for the quarter, compared to analysts’ expectations of $958.39 million. During the same period in the prior year, the company posted $2.65 EPS. Crocs’s revenue was up 1.6% compared to the same quarter last year. On average, sell-side analysts anticipate that Crocs will post 12.46 earnings per share for the current year.

Insider Activity at Crocs

In other Crocs news, Director John B. Replogle bought 1,972 shares of Crocs stock in a transaction that occurred on Thursday, March 14th. The shares were bought at an average price of $126.75 per share, with a total value of $249,951.00. Following the acquisition, the director now owns 3,153 shares in the company, valued at $399,642.75. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Crocs news, Director John B. Replogle bought 1,972 shares of Crocs stock in a transaction that occurred on Thursday, March 14th. The shares were bought at an average price of $126.75 per share, with a total value of $249,951.00. Following the acquisition, the director now owns 3,153 shares in the company, valued at $399,642.75. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Michelle Poole sold 4,793 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $119.15, for a total transaction of $571,085.95. Following the completion of the sale, the president now directly owns 64,912 shares in the company, valued at approximately $7,734,264.80. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 39,867 shares of company stock valued at $4,786,276. Insiders own 2.69% of the company’s stock.

Institutional Investors Weigh In On Crocs

Large investors have recently added to or reduced their stakes in the company. V Square Quantitative Management LLC bought a new stake in Crocs in the 1st quarter worth $25,000. Rise Advisors LLC bought a new stake in Crocs in the 1st quarter worth $25,000. Byrne Asset Management LLC grew its holdings in Crocs by 60.0% in the 4th quarter. Byrne Asset Management LLC now owns 320 shares of the textile maker’s stock worth $30,000 after acquiring an additional 120 shares during the last quarter. Blue Trust Inc. grew its holdings in Crocs by 185.0% in the 4th quarter. Blue Trust Inc. now owns 342 shares of the textile maker’s stock worth $32,000 after acquiring an additional 222 shares during the last quarter. Finally, Quest Partners LLC purchased a new stake in shares of Crocs in the 4th quarter worth about $53,000. Institutional investors own 93.44% of the company’s stock.

About Crocs

(Get Free Report)

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.

Featured Articles

Analyst Recommendations for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.